Table 5. KEGG pathways analysis.
Pathway ID | Pathway Term | DifGene | P-Value | FDR |
---|---|---|---|---|
PHF_catagen/PHF_telogen | ||||
PATH:03010 | Ribosome | 79 | 3.29×10−18 | 8.00×10−16 |
SHF_catagen/SHF_telogen | ||||
PATH:04530 | Tight junction | 16 | 5.62×10−5 | 1.20×10−2 |
PATH:05410 | Hypertrophic cardiomyopathy (HCM) | 11 | 4.35×10−4 | 4.51×10−2 |
PATH:05414 | Dilated cardiomyopathy | 11 | 6.63×10−4 | 4.51×10−2 |
PATH:05416 | Viral myocarditis | 9 | 8.47×10−4 | 4.51×10−2 |
SHF_catagen/PHF_catagen | ||||
PATH:04512 | ECM-receptor interaction | 29 | 2.27×10−6 | 6.09×10−4 |
PATH:04510 | Focal adhesion | 47 | 1.28×10−5 | 1.71×10−3 |
PATH:04974 | Protein digestion and absorption | 27 | 2.71×10−5 | 2.42×10−3 |
PATH:00480 | Glutathione metabolism | 18 | 1.19×10−4 | 6.92×10−3 |
PATH:03010 | Ribosome | 66 | 1.29×10−4 | 6.92×10−3 |
PATH:00980 | Metabolism of xenobiotics by cytochrome P450 | 21 | 5.37×10−4 | 2.40×10−2 |
PATH:05134 | Legionellosis | 19 | 1.19×10−3 | 4.55×10−2 |
PATH:05204 | Chemical carcinogenesis | 18 | 1.36×10−3 | 4.55×10−2 |
SHF_telogen/PHF_telogen |